BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu CS, Lee TY, Chao HW. Targeting glypican-3 as a new frontier in liver cancer therapy. World J Hepatol 2025; 17(9): 107671 [PMID: 41024885 DOI: 10.4254/wjh.v17.i9.107671]
URL: https://www.wjgnet.com/1948-5182/full/v17/i9/107671.htm
Number Citing Articles
1
Faris Alrumaihi, Reem A. Alromaihi, Vikalp Kumar, Shehwaz Anwar. Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular CarcinomaCurrent Issues in Molecular Biology 2025; 47(12): 1056 doi: 10.3390/cimb47121056
2
Ye-Qin Li, Yuan Liao, Wen Zhang, Guo-Wu Rao, Quan Zheng. Research progress of drugs targeting GPC3 in cancer therapyBioorganic Chemistry 2026; 169: 109383 doi: 10.1016/j.bioorg.2025.109383
3
Sina Nabiyi, Mohammad Heiat, Ehsan Rezaei. Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive reviewCytokine & Growth Factor Reviews 2026; 87: 89 doi: 10.1016/j.cytogfr.2025.12.006